SYDNEY, Australia, April 28, 2021 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), the leading developer of LAG-3 related immunotherapy treatments for cancer ...
SAN DIEGO and SUZHOU, China, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Adagene Inc. (ADAG), a company transforming the discovery and development of novel antibody-based therapies, today announced data at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback